G-CSF agonist (Axys/Amgen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameG-CSF agonist (Axys/Amgen)
Drug Alias NameG-CSF agonist (Arris/Amgen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsLeukopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArris Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArris Pharmaceutical CorpCeleraAmgen Inc
Active IndicationsN/A
Inactive IndicationsLeukopenia

Other Information

ATC CodeN/A
Related LinksN/A